News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Senior Diagnostics Executive Joins the biOasis Advisory Team
October 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER, British Columbia, Oct. 6, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) is pleased to announce that David Browning has agreed to advise the Company on its development programs for p97 diagnostic products.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
FDA
FDA taps Szarama as acting CBER director as Prasad’s tumultuous tenure ends
May 1, 2026
·
2 min read
·
Heather McKenzie
Earnings
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
April 30, 2026
·
5 min read
·
Gabrielle Masson
Earnings
Lilly’s weight loss pill reaches brand new patients, even without full-court marketing press
April 30, 2026
·
3 min read
·
Annalee Armstrong
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
April 30, 2026
·
2 min read
·
Tristan Manalac
